NCLAT: Can Set Aside Fraudulent Initiation of CIRP while hearing appeal u/s 61 of IBC  ||  NCLAT: Amount Belonging to Corpo. Debtor Can be Recovered by Liquidator by Filing Application u/s 60  ||  NCLAT: Can Admit Application u/s 7 of IBC if Interest on Principal Amount Crosses Threshold Limit  ||  Del. HC: Magistrates Cannot Question Validity of FIR under their Power to Supervise Investigation  ||  P&H HC: Victim Going With Accused to Crowded Place & Not Raising Alarm Shows Consensual Relationship  ||  Ker. HC: On Nature of Disability, AFT should Not Lightly Interfere with Opinion of Medical Board  ||  HP HC: When Award is Passed Without Giving Reasons, it Suffers from Patent Illegality  ||  SC: Refusing to Marry Someone Doesn’t Attract Offence of Abetment to Suicide  ||  SC: Can’t Deny Experience Marks to Candidate Performing Regular Duties in Unsanctioned Post  ||  NCLAT: Without Payment in Discharge of Guarantee, Guarantor Cannot Become Financial Creditor    

Participation of Foreign Portfolio Investors (FPIs) in Government securities on NDS-OM platform- (Reserve Bank of India) (20 Oct 2016)

MANU/RMIC/0187/2016

Banking

In terms of RBI circular FMRD.DIRD.06/14.03.007/2014-15 dated March 20, 2015, FPIs are currently permitted to transact in the Over-The-Counter (OTC) market for Government securities with T+2 settlement. As announced in paragraph 36 of the First Bi-monthly Monetary Policy Statement for the year 2016-17 on April 5, 2016, it has been decided to allow FPIs to trade Government securities in the secondary market through the primary members of NDS-OM including the Web-module. The primary members of NDS-OM shall be responsible for settlement of the trades, which will be on T+1 basis. This facility will become available with effect from December 1, 2016. The existing OTC route with T+2 settlement shall continue to be available to FPIs and subject to review. All other terms and conditions prescribed in the circular, ibid, remain the same.

Tags : FOREIGN PORTFOLIO   INVESTORS   PARTICIPATION  

Share :        

Disclaimer | Copyright 2024 - All Rights Reserved